Our focus is expanding affordable access to NARCAN® Nasal Spray – the leading community use naloxone – and progressing our pipeline of opioid overdose and addiction treatments.
Experienced Leadership in the US Specialty Pharma Industry
Chairman & Chief Executive Officer
Seamus Mulligan, founder of Adapt Pharma, serves as Chairman and Chief Executive Officer. Previously, Seamus was founder, Chairman, and Chief Executive Officer of Azur Pharma, which merged with Jazz Pharmaceuticals plc in 2012. Seamus continues to serve on the Board of Directors at Jazz Pharmaceuticals.
Our mission is to provide simple, reliable, and accessible therapeutic options, ensuring that patients, and those who care for them, have access to the right treatment at the right time.